A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
मुख्य लेखक: | Islam, Nahidul |
---|---|
अन्य लेखक: | Talukder, Mesbah |
स्वरूप: | थीसिस |
भाषा: | English |
प्रकाशित: |
Brac University
2023
|
विषय: | |
ऑनलाइन पहुंच: | http://hdl.handle.net/10361/22025 |
समान संसाधन
-
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
द्वारा: Afroza, Halima
प्रकाशित: (2024) -
Biologics and Biosimilars as Treatment Options for Psoriasis
द्वारा: Moya, Amena Khatun
प्रकाशित: (2023) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
द्वारा: Bishakha, Adwiza Chakraborty
प्रकाशित: (2024) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
द्वारा: Islam, S.M. Zahidul
प्रकाशित: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
द्वारा: Khandker, Tahia Anjum
प्रकाशित: (2024)